1
|
Tizzani A, Cassetta G, Cicigoi A, Piana P, Cerchier A, Pecchio F, Piantino P. Tumor Markers (CEA, TPA and CA 19–9) in Urine of Bladder Cancer Patients. Int J Biol Markers 2018; 2:121-4. [PMID: 3482861 DOI: 10.1177/172460088700200211] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
This study was carried out to evaluate the usefulness of determining urinary levels of carcinoembryogenic antigen (CEA), tissue-polypeptide antigen (TPA), and gastrointestinal cancer antigen (Cal 9-9) in addition to the usual diagnostic procedures for bladder cancer. Sixty-seven patients with transitional bladder cancer, 40 healthy controls and 20 patients with inflammatory diseases of the urinary tract were considered. All urine samples were obtained from patients with intact renal function and no urinary tract infection. TPA and Cal 9-9 urinary levels in patients with G3 bladder tumors were significantly higher than in those with lower graded neoplasms. The sensitivity, specificity, and predictive value of a positive (PV+) or negative (PV–) test and the diagnostic accuracy were also evaluated. Cal 9-9 was the best urinary marker for bladder cancer (sensitivity 71.6%, specificity 91.6%, PV + 90.5%, PV–74.3%, diagnostic accuracy 81%).
Collapse
Affiliation(s)
- A Tizzani
- Institute of Nephro-Urology, University of Turin
| | | | | | | | | | | | | |
Collapse
|
2
|
Abstract
Prostate-specific antigen (PSA) is a tissue-specific glycoprotein identified by Wang in 1979. It is synthesized in the prostate independently of prostatic acid phosphatase (PAP). A total of 199 subjects were divided into four groups: controls aged less than 50 years, controls aged more than 50 years, patients with benign prostatic hyperplasia (BPH) and patients with prostatic carcinoma. PSA cut-off value was set at 10 ng/ml (mean for the BPH group plus 2 SD). With this cut-off value PSA could not be used as an early predictor of prostatic carcinoma. The association of PSA and PAP in prostatic cancer increases the number of patients with positive biological markers.
Collapse
Affiliation(s)
- A Tizzani
- Institute of Nephro-Urology, University of Torino, Italy
| | | | | | | | | | | | | |
Collapse
|
3
|
Abstract
Neuroendocrine differentiation in prostatic malignancy is receiving considerable attention; this occurs commonly as a “focal” histological variant and, most rarely, in the form of small cell carcinoma (“oat cell carcinoma”) and carcinoid tumor. In prostate cancer, neuroendocrine differentiation may be the response to androgen deprivation and neuroendocrine products, either biogenic amines or peptides, have been shown to stimulate proliferation of androgen-ablation refractory cancer cells. Serum chromogranins, neuron-specific enolase and other neuroendocrine products as well as 111-In-chromogranin A “three step” immunoscintigraphy and somatostatin-receptor scintigraphy may be useful for predicting tumor behaviour and patient prognosis. Several of the neuroendocrine products, particularly somatostatin analogues, are candidates for new therapeutic approaches. The paper aims to outline the advances in this field on the basis of the review of the literature.
Collapse
Affiliation(s)
- C. Alberti
- I Clinica Urologica, Università degli Studi di Torino, Torino
| | - A. Tizzani
- I Clinica Urologica, Università degli Studi di Torino, Torino
| | - A. Greco
- I Clinica Urologica, Università degli Studi di Torino, Torino
| | - M. Piovano
- I Clinica Urologica, Università degli Studi di Torino, Torino
| |
Collapse
|
4
|
Fiorito C, Lucca I, Oderda M, Mondino P, Berta G, Cattaneo E, Valentino F, Zitella A, Pacchioni D, Tizzani A. Neuroendocrine bladder cancer: oncological emergency? Urologia 2018. [DOI: 10.1177/039156030807500111] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Neuroendocrine bladder cancer is extremely rare, with an estimated incidence of 0.5%- 0.7%. In bladder cancers there is no evident connection between the neuroendocrine phenotypic expression and the clinical history. However, prognosis is usually poor and the survival rate at 5 years does not exceed 8%, if untreated. Methods. We are here describing three case reports of bladder carcinoma with neuroendocrine differentiation, which is extremely aggressive and leads rapidly to death. At the present time, the local control of these tumors is achieved by radical cystectomy and radiotherapy; they can be both associated to chemotherapy. However, since these lesions are fairly rare, there is no gold standard therapy and there are no prospective studies on the management of these tumors. Conclusions. Considering the quick evolution and progression of any variant of the neuroendocrine tumors of the bladder, urologists and anesthetists should see them as real oncological emergencies. A prompt intervention through radical surgery with cystectomy and linfadenectomia, and the anathomo-pathologist's systematic investigation of the scraps could make the approach therapeutic and not only palliative. Prospective studies on neo-adjuvant chemotherapy as well as experimental studies about target therapies may yield new guidelines on the tumor management.
Collapse
Affiliation(s)
- C. Fiorito
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| | - I. Lucca
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| | - M. Oderda
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| | - P. Mondino
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| | - G. Berta
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| | - E.A. Cattaneo
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| | - F. Valentino
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| | - A. Zitella
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| | - D. Pacchioni
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| | - A. Tizzani
- Urologia I, ASO San Giovanni Battista-Molinette,
Torino
| |
Collapse
|
5
|
Abstract
The fusion of engineering with cell biology and advances in biomaterials may lead to de novo construction of implantable organs. Engineering of neobladder from autologous urothelial and smooth muscle cells cultured on biocompatible, either synthetic or naturally-derived substrates, is now feasible in preclinical studies and may have clinical applicability in the near future. The development of a bioartificial bladder would warrant the prevention of both the metabolic and neoplastic shortcomings of the intestinal neobladder. Two tissue-engineering techniques for bladder reconstruction have been tested on animals: 1) the in vivo technique involves the use of naturally-derived biomaterials for functional native bladder regeneration 2) the in vitro technique involves the establishment of autologous urothelial and smooth muscle cell culture from the host's urinary tract, after which the cells are seeded on the biodegradable matrix-scaffold to create a composite graft that is implanted into the same host for complete histotectonic regeneration. Waiting for the creation of a complete tissue-engineered bladder with a trigone-shaped base, we suggest, in surgical oncology after radical cystectomy, the realization of conduit or continent pouch using tissue-engineered material.
Collapse
Affiliation(s)
- C Alberti
- I Clinical Urology, University of Turin, Turin, Italy
| | | | | | | |
Collapse
|
6
|
Pacchioni D, Casetta G, Piovano M, Fraire F, Volante M, Sapino A, Tizzani A, Bussolati G. Prostatic Duct Carcinoma with Combined Prostatic Duct Adenocarcinoma and Urothelial Carcinoma Features. Int J Surg Pathol 2016; 12:293-7. [PMID: 15306945 DOI: 10.1177/106689690401200314] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
We report a unique case of prostatic duct carcinoma (PDC) featuring both prostatic duct adenocarcinoma (PDA) and high-grade urothelial carcinoma (HG-UC). An 84-year-old man presenting with hematuria showed at ultrasonography and cystoscopy a papillary neoplasia located near to the verumontanum. Histopathologic examination of specimens from transurethral resection revealed a tumor originating from large prostatic ducts showing 2 different components: PDA with endometrioid features (main pattern) and HG-UC (minor part). Immunohistochemically, the areas of PDA were positive for prostatic acid phosphatase (PAP), prostatic specific antigen (PSA), and androgen receptors (AR), while negative for estrogen (ER) and progesterone receptors (PGR). Prognostic factors evaluation pointed out a low proliferation index (10%) and focal expression of p53 (6%); c-erb-B2 was not overexpressed. The HG-UC areas were negative for all previous markers, while positive for thromobomodulin. The proliferation index was high (60%), and p53 was diffusely expressed (55%). The incidence and significance of PDC with combined features is discussed with reference to literature data.
Collapse
Affiliation(s)
- D Pacchioni
- Department of Urologic Pathology, University of Turin, Italy
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Tizzani A, Casetta G, Piana P, Carone R, Giona C, Rocca Rossetti S. Propionohydroxamic acid in the treatment of urease-induced calculi. Six months follow-up of 19 patients. Contrib Nephrol 2015; 58:212-4. [PMID: 3691130 DOI: 10.1159/000414520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- A Tizzani
- Università degli Studi di Torino, Facoltà di Medicina e Chirurgia, Italia
| | | | | | | | | | | |
Collapse
|
8
|
Minero C, Maggiorotti P, Barbeni M, Pelizzetti E, Tizzani A, Casetta G, Piana P, Giona C. Effect of inhibitors on the crystal growth of calcium oxalate. Contrib Nephrol 2015; 58:65-72. [PMID: 3691149 DOI: 10.1159/000414489] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- C Minero
- Dipartimento di Chimica Analitica, Cattedra di Urologia, Università di Torino, Italia
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Piana P, Casetta G, Giona C, Petrillo M, Tizzani A. Magnesium excretion in recurrent calcium urolithiasis. Evaluation of 46 hypercalciuric patients. Contrib Nephrol 2015; 58:115-7. [PMID: 3691114 DOI: 10.1159/000414499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- P Piana
- Università degli Studi di Torino, Facoltà di Medicina e Chirurgia, Istituto di Nefro-Urologia, Italia
| | | | | | | | | |
Collapse
|
10
|
Gontero P, Di Marco M, Giubilei G, Pisano F, Bonazzi A, Soria F, Fiorito C, Oderda M, Zitella A, Bartoletti R, Tizzani A, Mondaini N. UP-03.052 Combination of Andropenis® Penile Extender and Oral Therapy (Peironimev ®) Versus Intralesional Verpamil for Penile Curvature Due To Peyronie's Disease: Preliminary Results of a Randomized Phase II Trial. Urology 2011. [DOI: 10.1016/j.urology.2011.07.1142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
11
|
Gontero P, Spann M, Briganti A, Marchioro G, Tombal B, Hsu C, Vander EK, Bader P, Walz J, Frohneberg D, Graefen M, Montorsi F, Tizzani A, Van Cangh P, Van Poppel H, Joniau S. 679 IS SURGERY FOR HIGH-RISK LOCALIZED PROSTATE CANCER VALID IN THE ELDERLY POPULATION? AN ANALYSIS OF THE INFLUENCE OF AGE AN CANCER-SPECIFIC AND OVERALL SURVIVAL. ACTA ACUST UNITED AC 2010. [DOI: 10.1016/s1569-9056(10)60666-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
12
|
Spahn M, Gontero P, Kneitz B, Tombal B, Hsu CJ, Van der Eeckt K, Marchioro G, Bader P, Frohneberg D, Tizzani A, Van Poppel H, Joniau S. 578 PREDICTING PROSTATE CANCER SPECIFIC OUTCOME AFTER RADICAL PROSTATECTOMY AMONG MEN WITH PSA &[GE] 20 NG/ML WITH OR WITHOUT ADDITIONAL HIGH RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 712 PATIENTS. J Urol 2010. [DOI: 10.1016/j.juro.2010.02.837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
13
|
Ciammella P, Badellino S, Botticella A, Filippi A, Valentino F, Gontero P, Tizzani A, Ricardi U. 7012 Evaluation of the efficacy and safety of Tadalafil 20 mg on demand vs Tadalafil 5 mg once-a-day in the treatment of erectile dysfunction following curative radiotherapy for prostatic carcinoma: preliminary results of a randomized phase II trial. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71390-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
14
|
Fonzo D, Manenti M, Varengo M, Quadri R, Frea B, Tizzani A, Carone R. Andrological and hormonal findings in subjects with ductus deferens agenesia. Andrologia 2009; 15 Spec No:614-8. [PMID: 6421195 DOI: 10.1111/j.1439-0272.1983.tb00226.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Abstract
The aim of our study has been the complete andrological and endocrinological evaluation of seven cases of bilateral ductus deferens agenesia. In all cases testicular biopsy demonstrated a normal spermatogenesis. Urographic examination showed, in four cases, the existence of congenital anomalies of the urinary tract. The presence of spermioagglutinating and spermimmobilizing antibodies in blood and in seminal plasma was excluded in all cases. Basal and stimulated levels of FSH, LH, PRL and testosterone were within normal limits. Surgical exploration of seminal tracts and bilateral collection of sperm at the caudal portion of the epididymis appear to be mandatory in order to select the cases for surgical therapeutic approach.
Collapse
|
15
|
Oderda M, Mondino P, Zitella A, Tizzani A, Gontero P. Quality of life in elderly bladder cancer patients following cystectomy and urinary diversion. ACTA ACUST UNITED AC 2008. [DOI: 10.2217/1745509x.4.6.659] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
This review aims to provide information about quality of life in elderly patients who have undergone radical cystectomy and bladder replacement for muscle-invasive bladder cancer, focusing on the best instruments for evaluation. Among patients over 75 years of age, bladder cancer is the fifth leading cause of death. Radical cystectomy is the standard treatment for muscle-invasive bladder cancer and it is also considered safe in the elderly population. Quality of life is an essential aspect following radical cystectomy and bladder replacement owing to its impact on patients’ satisfaction with body image and urinary, sexual and social functioning. Furthermore, the authors suggest that there are no significant differences between different methods of urinary diversion in the elderly.
Collapse
Affiliation(s)
- M Oderda
- University of Turin, Urologia 1 Molinette Hospital Corso Dogliotti 14, Torino, Italy
| | - P Mondino
- University of Turin, Urologia 1 Molinette Hospital Corso Dogliotti 14, Torino, Italy
| | - A Zitella
- University of Turin, Urologia 1 Molinette Hospital Corso Dogliotti 14, Torino, Italy
| | - A Tizzani
- Head of Department of Urology University of Turin, Urologia 1 Molinette Hospital Corso Dogliotti 14, Torino, Italy
| | - P Gontero
- Lecturer & Consultant Urologist, University of Turin, Urologia 1 Molinette Hospital Corso Dogliotti 14, Torino, Italy
| |
Collapse
|
16
|
Oderda M, Mondino P, Zitella A, Gontero P, Tizzani A. Update on epidemiology and risk factors of prostate cancer. Urologia 2008. [DOI: 10.1177/039156030807500301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Prostate cancer is one of the most common malignancies in the world; more and more men are being diagnosed with prostate cancer worldwide. According to epidemiological studies, prostate cancer will become the most common male cancer by 2010, with 900,000 cases per year. Nevertheless, although the constant increase in incidence, knowledge about the aetiology and risk factors of this tumour is still poor. Several important issues could foster the understanding and prevention of this disease, such as the variation in incidence of prostate cancer between ethnic populations, studies on migrants, dietary and genetic factors. Here we provide an update on epidemiology and risk factors of prostate cancer.
Collapse
Affiliation(s)
- M. Oderda
- Urologia I, ASO San Giovanni Battista Molinette
| | - P. Mondino
- Urologia I, ASO San Giovanni Battista Molinette
| | - A. Zitella
- Urologia I, ASO San Giovanni Battista Molinette
| | - P. Gontero
- Urologia I, ASO San Giovanni Battista Molinette
| | - A. Tizzani
- Urologia I, ASO San Giovanni Battista Molinette
| |
Collapse
|
17
|
Oderda M, Mondino P, Zitella A, Gontero P, Tizzani A. [Update on epidemiology and risk factors of prostate cancer]. Urologia 2008; 75:143-148. [PMID: 21086342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Prostate cancer is one of the most common malignancies in the world; more and more men are being diagnosed with prostate cancer worldwide. According to epidemiological studies, prostate cancer will become the most common male cancer by 2010, with 900,000 cases per year. Nevertheless, although the constant increase in incidence, knowledge about the aetiology and risk factors of this tumour is still poor. Several important issues could foster the understanding and prevention of this disease, such as the variation in incidence of prostate cancer between ethnic populations, studies on migrants, dietary and genetic factors. Here we provide an update on epidemiology and risk factors of prostate cancer.
Collapse
|
18
|
Terrone C, Gontero P, Volpe A, Porpiglia F, Bollito E, Zattoni F, Frea B, Tizzani A, Fontana D, Scarpa RM, Rossetti SR. Proposal of an improved prognostic classification for pT3 renal cell carcinoma. J Urol 2008; 180:72-8. [PMID: 18485380 DOI: 10.1016/j.juro.2008.03.029] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2007] [Indexed: 10/22/2022]
Abstract
PURPOSE The prognostic accuracy of the current TNM 2002 staging system for locally advanced renal cell carcinoma has been questioned. To contribute to the development of a more accurate classification for this stage of disease we assessed the correlation between patterns of invasion in the pT3 category and outcomes in a large multi-institutional series. MATERIALS AND METHODS Pathological data and clinical followup on 513 pT3 renal cell carcinoma cases treated with radical nephrectomy between 1983 and 2005 at 3 Italian academic centers were retrospectively reviewed. Cause specific survival rates were calculated with the Kaplan-Meier method and multivariate analysis was performed using the Cox proportional hazards regression model. RESULTS Estimated overall 5-year cause specific survival was 50.1% at a median followup of 61.5 months in survivors. The current TNM classification was not a significant outcome prognosticator. Patients with a tumor invading only the perirenal or sinus fat were at lowest risk for death from the disease. Patients at intermediate risk had tumors with invasion of the venous system alone. Simultaneous perirenal fat and sinus fat invasion or perirenal fat and vascular invasion as well as adrenal gland involvement characterized high risk tumors. Low risk tumors could be further divided into 2 groups with different outcomes based on a size cutoff of 7 cm. Our classification was a significant predictor of survival on multivariate analysis as well as M stage, N stage, Fuhrman grade and tumor size. CONCLUSIONS We confirm that the prognostic usefulness of the current 2002 TNM system for pT3 renal cell carcinoma is limited. We have identified 4 groups of tumors with distinct patterns of invasion and significantly different survival probabilities in this category. Large prospective series are needed to validate these findings.
Collapse
Affiliation(s)
- C Terrone
- Department of Urology, Azienda Ospedaliera Maggiore della Carità, Novara, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Joniau S, Gontero P, Marchioro G, Tizzani A, Frea B, Van Poppel H. RADICAL PROSTATECTOMY FOR LOCALLY ADVANCED PROSTATE cancer with psa ≥ 20 ng/ml. ACTA ACUST UNITED AC 2008. [DOI: 10.1016/s1569-9056(08)60129-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
20
|
Ghignone GP, Piana P, Greco A, Zitella A, De Libero A, Petraz M, Tizzani A. [Leiomyosarcoma of the vessels of the renal ileus : a case report]. MINERVA UROL NEFROL 2006; 58:174. [PMID: 17124490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
|
21
|
Ghignone GP, Petraz M, Casetta G, Greco A, Zitella A, Fiorio M, Buffa Di Perrero E, Tizzani A. [Adenocarcinoma of the scrotum: a case report]. MINERVA UROL NEFROL 2006; 58:173-4. [PMID: 17124489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
|
22
|
Ridolfi R, Matera L, Tizzani A. Immunotherapy for Urologic Tumors. Urologia 2006. [DOI: 10.1177/039156030607300401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Cancer vaccines are intended to promote a long-lasting memory response against tumors. Rationale for cancer vaccines is based on two observations: a) many tumors express antigens (TA), which are recognized by specific cytotoxic T lymphocytes; b) these lymphocytes may protect the host against tumor growth in vivo. So far, cancer vaccines have been developed using soluble TA and, more recently, TA presented by dendritic cells (DC), the most powerful antigen presenting cells (APC). DCs play a key role in the process leading to antigen recognition and lymphocyte activation. Despite a deeper understanding of these processes, clinical efficacy of cancer vaccines is still hampered by the heterogeneity of the studies performed so far, and by the largely unknown mechanisms through which tumors escape immunosurveillance. Current DC-based cancer vaccines require the preparation of DCs from patient blood monocytes, as well as DC-loading with TA. Both whole tumor and TA peptides are used as source of TA. Similar schedules have been implemented in many clinical trials on melanoma, kidney and prostate cancer, with partial responses ranging from 7% to 30%. The study population was made up of non-respondent patients to any other therapy; the DC vaccination showed an extremely low toxicity. 22 patients with metastatic melanoma received a DC vaccine in Forlì (Italy) since August 2001. Good correlation between immunologic response, clinical response and overall survival was found. A clinical trial on pulsed APC administration to patients with recurring prostate cancer is ready to be started in Torino (Italy), pending the Ministerial approval from a local cell factory.
Collapse
Affiliation(s)
- R. Ridolfi
- Dipartimento di Oncologia Medica, Istituto Oncologico Romagnolo-IRST, Forlì
| | - L. Matera
- Laboratorio Immunologia dei Tumori, Dipartimento Medicina Interna
| | - A. Tizzani
- I Clinica Urologica, Università degli Studi di Torino
| |
Collapse
|
23
|
Alberti C, Piovano M, Tizzani A. Uroangiographic Contrast Media-Induced Nephropathy: Correlations between Their Physicochemical Properties and Renal Damage. Urologia 2005. [DOI: 10.1177/039156030507200405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Contrast media-induced nephropathy (CN) is an important cause of hospital-acquired acute renal failure. Patients with both diabetes mellitus and renal impairment are at high risk. CN pathophysiology involves activation of the tubulo-glomerular feedback and vasoactive mediators such as renin-angiotensin 2, endothelin, adenosine, ADH, etc. The risk of CN can be minimized by the use of non-ionic, low or isoosmolar, contrast material, adequate hydration and prophylactic pharmacological measures. In patients with chronic renal failure who are undergoing arteriography (e.g. coronary angiography and angioplasty), periprocedural hemofiltration appears effective in preventing further renal damage due to contrast agents.
Collapse
Affiliation(s)
- C. Alberti
- I Clinica Urologica, Università degli Studi di Torino
| | - M. Piovano
- I Clinica Urologica, Università degli Studi di Torino
| | - A. Tizzani
- I Clinica Urologica, Università degli Studi di Torino
| |
Collapse
|
24
|
Zaramella S, Rossetti SR, Tizzani A, Frea B. Fatal Hemorrhage during Nephrolithotomy in a Patient with Unknown Vascular Ehlers-Danlos Syndrome Type IV. Urologia 2005. [DOI: 10.1177/039156030507200307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Ehlers-Danlos syndrome type IV (vascular EDS), is a life-threatening inherited connective tissue disorder resulting from mutations in the COL3A1 gene coding for type III procollagen. Vascular EDS causes severe fragility of connective tissues. We report a case of a 26-year-old male with bilateral staghorn renal calculi, the patient underwent a left nephrolithotomy, during the suspension of the renal artery incredibly, it was lacerated by the vessel loop, without any actraction. Subsequently, all hemostatic attempts, although gentle, resulted in important and catastrophic aortic and caval injures; the patient died due to an uncontrollable abdominal and thoracic hemorrhage. The early diagnosis of the vascular EDS is difficult if there are no known cases. Every surgical procedure in patients with Enlers-Danlos syndrome has a high risk of fatal vascular injuries.
Collapse
Affiliation(s)
- S. Zaramella
- Clinica Urologica, Facoltà di Medicina e Chirurgia, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Az. Ospedaliera “Maggiore della Carità”, Novara
| | | | - A. Tizzani
- Cattedra di Urologia, Università degli Studi di Torino
| | - B. Frea
- Clinica Urologica, Facoltà di Medicina e Chirurgia, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Az. Ospedaliera “Maggiore della Carità”, Novara
| |
Collapse
|
25
|
Graziano M, Casetta G, Tasso M, Volpe A, Ferrando U, Tizzani A. Insuline-Like Growth-Factors (IGFs) as Marker of Risk and Progression of Prostate Cancer. Urologia 2004. [DOI: 10.1177/039156030407100206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The growing incidence of prostate cancer is stimulating investigations on cancer differentiation and proliferation. Studies on guinea-pigs showed IGF can cause and stimulate cancer as hepatocarcinoma, breast cancer, pancreas cancer and prostate cancer. Between April 2001 and February 2002 we investigated 17 patients (50–75 years old) with prostate cancer. IGF1 serum concentration before surgery was higher than physiological level, at 2 months and, above all, at 6 months after radical prostatectomy this level decreased significantly. Furthermore IGF growing was related with protein and hormone variations (protein and hormone levels were measured before surgery, at 2 and 6 months after surgery; BMI was measured in the same periods). IGF1R concentration on the prostate glande was low expressed as we showed with immunohistochemistry: this could mean a low sensibility to apoptosis. IGF1/PSA was significantly low in patients with prostate cancer. These results suggest the possible role of IGF1 in differentiation-progression of prostate cancer and in metabolic alterations. Other studies about IGF might investigate its diagnostic and therapeutic role.
Collapse
Affiliation(s)
- M.E. Graziano
- Struttura Complessa Urologia 3 DO Azienda Ospedaliera San Giovanni Battista, Torino
| | - G. Casetta
- Struttura Complessa Urologia 1 DU, Azienda Ospedaliera San Giovanni Battista, Torino
| | - M. Tasso
- Struttura Complessa Urologia 3 DO Azienda Ospedaliera San Giovanni Battista, Torino
| | - A. Volpe
- Struttura Complessa Urologia 3 DO Azienda Ospedaliera San Giovanni Battista, Torino
| | - U. Ferrando
- Struttura Complessa Urologia 3 DO Azienda Ospedaliera San Giovanni Battista, Torino
| | - A. Tizzani
- Struttura Complessa Urologia 1 DU, Azienda Ospedaliera San Giovanni Battista, Torino
| |
Collapse
|
26
|
Casetta G, Vaccino D, DE Libero A, Bernardi D, Tessa M, Beltramo G, Ricardi U, Tizzani A. Permanent Interstitial Brachytherapy in the Treatment of Localized Prostatic Carcinoma: The Piedmont Experience. Urologia 2004. [DOI: 10.1177/039156030407100113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The modern interstitial brachytherapy plays a first-rate role in the treatment of the organ-confined prostatic carcinoma as a substantial alternative to radical prostatectomy and external beam radiotherapy in selected patients. Materials and Methods In our Centre 50 patients with a localized prostatic carcinoma were treated with transperineal and transrectal ultrasound-guided permanent implantation of I-125 radioactive seeds. 35 patients also underwent a neoadjuvant hormonal-therapy. Main end points were the biochemical control of the neoplasia and the treatment complications during a 24 months follow-up. Results We had two biochemical neoplasia recurrences, both in the neoadjuvant group. The most frequently observed complications were: slight irritative symptoms (12%), severe irritative symptoms (30%), urinary retention (10%), hematuria (8%), loss of seeds (6%), erectile dysfunction (46%). Urinary incontinence, urethral stricture and proctitis were not observed. Conclusions So far no large clinical trial compared the clinical efficacy of interstitial brachytherapy versus the other “conventional” treatments options (radical prostatectomy, external beam radiotherapy). The results of our study and the actual evidences, based on cohort observation studies and case-control ones comparing brachytherapy versus surgery or external irradiation, support the therapeutical value of permanent interstitial implant with regard to oncological results and complications.
Collapse
Affiliation(s)
- G. Casetta
- Clinica Urologica I Università di Torino, Torino
| | - D. Vaccino
- Clinica Urologica I Università di Torino, Torino
| | - A. DE Libero
- Clinica Urologica I Università di Torino, Torino
| | - D. Bernardi
- Clinica Urologica I Università di Torino, Torino
| | - M. Tessa
- Radioterapia, Università di Torino, Torino
| | | | - U. Ricardi
- Radioterapia, Università di Torino, Torino
| | - A. Tizzani
- Clinica Urologica I Università di Torino, Torino
| |
Collapse
|
27
|
Gontero P, Casetta G, Maso G, Sogni F, Zitella A, Frea B, Tizzani A. 859 Intravesical gemcitabine in the treatment of intermediate risk superficial transitional cell carcinoma (TCC) of the bladder: a marker lesion study. EJC Suppl 2003. [DOI: 10.1016/s1359-6349(03)90885-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
28
|
Alberti C, Tizzani A. [Prostate cancer-related metastatic bone disease. Some new acquisitions about pathogenesis an therapeutic approaches]. MINERVA UROL NEFROL 2003; 55:147-55. [PMID: 14610434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
Anatomic patterns of blood flow and specific dynamic interactions between prostate cancer cell and bone microenvironment influence the distribution of metastatic deposits. Bone components preferentially bind cancer cell and can facilitate tumor growth in bone; cancer cells, in turn, can release some factors that enhance osteoblastic activity. Recent studies, in animal models, have provided evidences of chemoattractant factors (bone homing factors) and of an enhanced adherence of prostate cancer cells to bone marrow endothelium. Additional data suggest "osteomimetic" pattern of prostate cancer cells after their arrival in bone, particularly by taking an osteoblastic behavior. The presence of the cancer cell in bone results in bone matrix increased turnover. Although prostate cancer is characterized by osteoblastic metastases, bone resorption is a regular feature of this tumor and is a necessary factor for its invasiveness in bone. Current treatment options based on radiotherapy and pharmacotherapy are essentially palliative. The bisphoshonates inhibit osteoclastic bone degradation by several mechanisms. Improved knowledges of the molecular mechanisms in the development of skeletal metastases allow to foresee biologically-based therapeutic strategies.
Collapse
Affiliation(s)
- C Alberti
- Clinica Urologica I, Dipartimento di Discipline Medico-Chirurgiche, Università degli Studi di Torino, Torino, Italy
| | | |
Collapse
|
29
|
Rosso D, Ghignone GP, Bernardi D, Zitella A, Casetta G, De Zan A, Tizzani A. Clear cell sarcoma of the kidney with invasion of the inferior vena cava. Urol Int 2003; 70:251-2. [PMID: 12660471 DOI: 10.1159/000068756] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2001] [Accepted: 09/20/2001] [Indexed: 11/19/2022]
Abstract
OBJECTIVE We present a case of clear cell sarcoma of the kidney (CCSK) in 53-year-old white man who was treated with surgery. This case represents the oldest patient with CCSK published in the English literature. METHODS Right radical nephrectomy with lymphadenectomy and thrombectomy was performed. RESULTS Histological findings indicated a CCSK. Tumor cells showed positive vimentin staining. CONCLUSION CCSK is considered a rare and highly malignant renal tumor. The malignant nature may relate not only to the biological features of these tumor cells, but also to the high resistance against radiation and chemotherapy. The treatment of CCSK has been a subject of controversy.
Collapse
Affiliation(s)
- D Rosso
- Department of Urology, University of Turin, Corso A.M. Dogliotti 14, I-10126 Turin, Italy.
| | | | | | | | | | | | | |
Collapse
|
30
|
Alberti C, Tizzani A. Ureteropelvic Junction Obstruction: Some new Acquisitions about Etiology, Pathophysiology and Diagnostics. Urologia 2003. [DOI: 10.1177/039156030307001-402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The etiopathogenesis of uretero-pelvic junction obstruction (UPJO) has been the subject of many speculations and it remains, in some ways, a debatable matter. Some recently reported thorough research refer to neuro-mediated pathogenetic mechanisms rather than (or together with) myogenic ones.Advances in US, radioisotopic functional imaging, CT and RM contribute to differentiate the obstructive conditions from the non-obstructive ones and to afford today a better assessment of renal functional damage. Particularly, diuretic renography is a non-invasive test for characterization of the renal functional abnormalities resulting from UPJO. Helical CT with angiography is a useful technique for identification of crossing vessels (pyelo-vascular tangle) which can be used for the pre-surgical planning of endopyelotomy. Endoluminal ultrasonography can be used to guide the position of the incision for endopyelotomy (US-guided endopyelotomy).Laboratory examinations are important to determine the overall renal function (serum creatinine, acid-base balance, serum electrolytes, etc.), urinary MCP-1 and NAG (markers of tubular damage), and to rule out urinary tract infections.The management of UPJO (watchful waiting; either open or laparoscopic dismembered pyeloplasty; endoluminal procedures) is greatly influenced by the diagnostic evaluation.The paper aims to outline the advances in both physiopathology and diagnostics of UPJO on the basis of a review of the literature.
Collapse
Affiliation(s)
- C. Alberti
- Ia Clinica Urologica dell'Università degli Studi di Torino, Torino
| | - A. Tizzani
- Ia Clinica Urologica dell'Università degli Studi di Torino, Torino
| |
Collapse
|
31
|
De Luca S, Terrone C, Crivellaro S, De Zan A, Polo P, Vigliani MC, Tizzani A. Opsoclonus-myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma. a case report and review of the literature. Urol Int 2002; 68:206-8. [PMID: 11919472 DOI: 10.1159/000048454] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Opsoclonus is a rare but distinctive disorder of ocular motility, characterized by irregular, continual and conjugated chaotic saccades of the eyes. It is increased with eye closure and fixation, and it persists during sleep. Opsoclonus appears more commonly in children and in half of such cases in association with neuroblastoma. In adults the most frequent causes are idiopathic (50%) and paraneoplastic (20%). Among the second group, different types of tumors involving a wide variety of organs have been reported. Opsoclonus when accompanied by other symptoms of central nervous system involvement (head, appendicular myoclonus and truncal ataxia) constitutes a clinical picture, known as opsoclonus-myoclonus syndrome. We report the case of a young patient affected by renal cell carcinoma associated with opsoclonus-myoclonus syndrome which did not respond to medical therapy but dramatically improved after cancer ablation.
Collapse
Affiliation(s)
- S De Luca
- Urological Clinic, Department of Medical and Surgical Disciplines, University of Torino, Italy.
| | | | | | | | | | | | | |
Collapse
|
32
|
Casetta G, Moiso A, Zitella A, Tizzani A. [Communication between urologist and pathologist. Proposal for the standardization of histological tests requests for neoplasms]. MINERVA UROL NEFROL 2001; 53:221-9. [PMID: 11753250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
The aim of this work is to propose a new clinical data system which should accompany the histological sample for the histologic diagnosis made by the pathologist. Six different schedules on the most important urological tumours are presented: prostate (needle biopsies and surgical approach), bladder (endoscopic procedure and open surgery), kidney and ureter, testis. In each schedule the urologist provides, in a scheme, the clinical report needed for the pathologist's final diagnosis. A clear explanation of the clinical data and a faster method of filling in the form are the qualifying elements of these schedules.
Collapse
Affiliation(s)
- G Casetta
- Divisione Universitaria di Patologia Urologica, Università degli Studi, Turin, Italy
| | | | | | | |
Collapse
|
33
|
Gontero P, Tizzani A, Muir GH, Caldarera E, Macaluso MP. The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic value. Urol Res 2001; 29:377-87. [PMID: 11828990 DOI: 10.1007/s002400100216] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
This review focuses on the main oncogenes studied in transitional cell carcinoma (TCC) in order to describe their mechanisms of action and investigate their possible prognostic value. Each oncogene family is reported following the order through which the proliferative signal is transduced from the extracellular space via a growth factor to the nucleus where transcription factors are switched on. Oncogenic activation at any level of the pathway will cause an increased transcription of genes enhancing the cell cycle, and proliferation will therefore be amplified. The main molecular or immunohistochemical studies from the literature on the aberrant expression of these genes are examined and compared with the aid of tables. Conclusions suggest that, although some may initially appear promising, no oncogene, has thus far been found to have a definite prognostic value superior to conventional grading and staging.
Collapse
Affiliation(s)
- P Gontero
- Patologia Urologica, Universita' di Torino, Italy.
| | | | | | | | | |
Collapse
|
34
|
Volante M, Tizzani A, Casetta G, Zitella A, Pacchioni D, Bussolati G. Progression from superficial to invasive carcinoma of the bladder: genetic evidence of either clonal heterogeneous events. Hum Pathol 2001; 32:468-74. [PMID: 11381363 DOI: 10.1053/hupa.2001.24330] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Until now, no definitive molecular evidence proving or disproving a true progression from superficial to invasive bladder tumors has been reported. A total of 36 lesions from 6 patients affected by invasive bladder cancer after multiple superficial recurrences were analyzed for loss of heterozygosity on 8 loci of chromosome 9 and 2 loci of chromosome 17. In addition, the clonal composition of the tumors from two female patients was examined using the human androgen receptor assay. Our data suggest that papillary bladder lesions can and sometimes do make a true progression into invasive life-threatening tumors; however, this progression is not an invariable sequence because it was definitely proven in 2 but not confirmed in 3 of the cases we examined.
Collapse
Affiliation(s)
- M Volante
- Department of Biomedical Sciences and Oncology, University of Turin, Turin, Italy
| | | | | | | | | | | |
Collapse
|
35
|
Priolo G, Gontero P, Martinasso G, Mengozzi G, Formiconi A, Pelucelli G, Zitella A, Casetta G, Viberti L, Aimo G, Tizzani A. Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer. Clin Chim Acta 2001; 305:47-53. [PMID: 11249922 DOI: 10.1016/s0009-8981(00)00416-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
BACKGROUND The study was aimed at comparing the diagnostic accuracy of the quantitative bladder tumor antigen (BTA) TRAK immunoassay with exfoliative urine cytology in the detection of primary and recurrent bladder cancer. METHODS The analysis was carried out on 194 high risk patients undergoing a diagnostic cystoscopy, 279 patients with previous history of transitional cell carcinoma awaiting a follow-up cystoscopy, and 45 healthy controls. Urine cytology was performed by a skilled cytopathologist on three consecutive samples. RESULTS BTA TRAK values resulted significantly higher in tumor positive cases than in absence of bladder tumor for both groups of patients. Non neoplastic urothelial diseases as well as the absence of mucosal abnormalities were associated with a marked increase in BTA TRAK levels with respect to the control group. Overall sensitivity and specificity was 63 and 63% for BTA TRAK (cut-off 34 U/ml), and 68.3 and 73.4% for urine cytology, respectively. The diagnostic advantage of urine cytology was maintained when patients were stratified by tumor grade. CONCLUSIONS The clinical performance of the BTA TRAK in the detection of primary or recurrent bladder cancer is acceptable and reproducible as shown by similar results with previous reports, although urine cytology performed on three samples showed the highest sensitivity and specificity.
Collapse
Affiliation(s)
- G Priolo
- Laboratory of Clinical Chemistry, San Giovanni Battista Hospital, Corso Bramante 88, 10126, Turin, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Abstract
We report a case of a 75-year-old female with pheochromocytoma of the bladder. Clinical evaluation included ultrasonography, intravenous pyelography, CT scan, I-MIBG scintiscan. A transurethral resection was performed for a exophytic tumor of 2 cm diameter. The histological result indicated the diagnosis of bladder pheochromocytoma. Three years later the patient remains disease free. Preoperative diagnosis is established by determination of blood and urine levels of catecholamines and their metabolites is a nonspecific diagnostic tool. The sensitivity of CT scan is 82%. Iodine-methyliodobenzylguanidine (I-MIBG), used by scintiscanning, specifically accumulates in pheochromocytomas. Life-long follow-up is necessary to diagnose late recurrences.
Collapse
Affiliation(s)
- C Baima
- Department of Urology (Head: Prof. A. Tizzani), University of Turin, Italy.
| | | | | | | |
Collapse
|
37
|
Casetta G, Gontero P, Zitella A, Pelucelli G, Formiconi A, Priolo G, Martinasso G, Mengozzi G, Aimo G, Viberti L, Tizzani A. BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder. Urol Int 2001; 65:100-5. [PMID: 11025432 DOI: 10.1159/000064848] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
PURPOSE Both BTA TRAK and NMP22 urine concentrations have shown a sensitivity superior to urine cytology in the detection of bladder cancer. We compared these tumor markers with urine cytology performed on 3 consecutive samples and evaluated by an expert cytopathologist. PATIENTS AND METHODS The investigations were conducted on 94 patients undergoing a diagnostic cystoscopy for a high suspicion of bladder cancer (group 1) and on 102 patients with previous history of transitional cell carcinoma awaiting a follow-up cystoscopy (group 2). Biopsy specimens were obtained also from tumor negative patients. Immunoassays for BTA TRAK and NMP22 were carried out according to standard methods. The choice of the cut-off was based on the ground of sensitivity and specificity curves intersection. Urine cytology results were expressed as positive, negative and 'dubious'. RESULTS Overall sensitivity was 56% for NMP22 (cut-off 11 U/ml) and 57% for BTA TRAK (cut-off 60 U/ml). When dubious results were considered as positive cases, urine cytology achieved a sensitivity of 73.3%. Assuming dubious cases as negative results, urine cytology sensitivity resulted 59.3%. When the 2 groups of patients were evaluated separately with different cut-off, there was no significant gain in sensitivity for BTA TRAK and NMP22 over urine cytology. CONCLUSIONS Urine cytology performed on 3 samples showed the highest sensitivity and specificity. The diagnostic advantage of urine cytology over BTA TRAK and NMP22 was maintained when patients were stratified by tumor grade.
Collapse
Affiliation(s)
- G Casetta
- Department of Urology, University of Torino, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
De Luca S, Milan GL, Zitella A, Castelli E, Greco A, Tizzani A. [Large calcifications on double J ureteral endoprosthesis "forgotten" in situ. Report of a clinical case]. MINERVA UROL NEFROL 2000; 52:211-4. [PMID: 11315332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Ureteral endoprostheses can be complicated by incrustations, sometimes making it impossible to withdraw the stent. A case in which the use of cistolithotripsy and of extracorporeal shock-wave lithotripsy (ESWL) allowed withdrawal of a double J ureteral stent with large incrustations is reported. The stent was placed 3 years before. Epidemiology, aetiology and therapeutic aspects of encrusted ureteral stents are discussed.
Collapse
Affiliation(s)
- S De Luca
- Clinica Urologica, Dipartimento di Discipline Medico-Chirurgiche, Università degli Studi, Torino
| | | | | | | | | | | |
Collapse
|
39
|
Gontero P, Casetta G, Zitella A, Ballario R, Pacchioni D, Magnani C, Muir GH, Tizzani A. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder. Eur Urol 2000; 38:287-96. [PMID: 10940702 DOI: 10.1159/000020295] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
OBJECTIVES To confirm the interrelationship between p53, ki67, mitotic index with others known prognostic factors such us stage, grade, multifocality, tumour size, history of recurrence in transitional cell carcinoma (TCC) of the bladder and to determine the prognostic impact of p53, Ki67 and mitotic index in predicting recurrence in superficial bladder cancer. METHODS Two hundred and fourteen patients with apparently superficial TCC of the bladder underwent TURBT and the 192 histologically Ta-T1 were divided into 104 primary lesions (group 1, mean follow-up 26 months) and 88 recurrent tumours (group 2, mean follow-up 28 months). Data concerning focality, tumour size, number of recurrences and recurrence-free survival were considered in each patients. All samples were immunohistochemically stained with p53 and Ki67 monoclonal antibodies. Mitotic index (MI) was calculated on haematoxylin and eosin stained sections. RESULTS Recurrence-free survival was significantly lower in superficial recurrent tumours (group 2) compared with primary tumours (group 1). P53 staining was correlated with grade and stage for both 5 and 20% positivity thresholds. Ki67 and MI were significantly different over strata defined by stage, grade and focality in both patients groups but only Ki67 showed a correlation with p53 status. Recurrence-free survival could not be predicted either by p53 status or MI. A 20% cut-off level of Ki67 staining resulted a good predictor of recurrence in group 1 Ta-T1/G1-G2 tumours (p = 0.03). Only Ki67 and multifocality were found to be independent prognostic factors of recurrence in multivariate analysis. Stratifying Ta-T1/G1-G2 patients according to these variables, Ki67 provided a useful tool to predict early recurrence in monofocal lesions from both groups. CONCLUSIONS P53 and MI despite a fairly good correlation with traditional prognostic factors in bladder TCC seem to play no role in the prediction of tumoural recurrence. A Ki67 index over 20% predicts those single well-differentiated (Ta-T1/G1-G2) tumours which are likely to recur within one year of treatment.
Collapse
Affiliation(s)
- P Gontero
- Division of Patologia Urologica, University of Torino, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Sier CF, Casetta G, Verheijen JH, Tizzani A, Agape V, Kos J, Blasi F, Hanemaaijer R. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers. Clin Cancer Res 2000; 6:2333-40. [PMID: 10873084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Matrix metalloproteinases (MMPs) are involved in tumor growth and metastasis, promoting the migration and invasion of cells. In this study, the amount of MMP-2 and MMP-9 activity was measured in urine from superficial bladder carcinoma patients (pTa, pT1) to evaluate their possible diagnostic value. The active and total amount of MMP-2 and MMP-9, respectively, in urine from tumor patients were compared with the levels in urine from age- and gender-matched healthy volunteers. Both MMP-2 and MMP-9 activity levels were significantly enhanced in urine from patients with high invasive cancers (pT2, PT3), whereas in urine from healthy controls no or very low MMP activities were found. More importantly, a substantial number of urine samples from patients with superficial tumors contained elevated MMP-2 and MMP-9 activities, suggesting that enhanced urinary MMP activity levels, indeed, might be indicative for early-stage bladder cancer. Overall, urinary MMP-2 and MMP-9 activity levels were significantly correlated to each other, with some individual exceptions. A comparison between urinary MMP-9 activity and a recently proposed urinary marker for bladder cancer, NMP-22, showed slightly lower numbers of patients with elevated levels for MMP-9. But because MMP-9 and NMP-22 levels were not correlated, enhanced urinary MMP activity might be useful as a marker for superficial bladder carcinoma like, or especially in combination with, other markers.
Collapse
Affiliation(s)
- C F Sier
- Department of Molecular Pathology and Medicine DIBIT, San Raffaele Scientific Institute, Milan, Italy
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Tizzani A, Casetta G, Gontero P. [Screening for prostate cancer: reasons for, reasons against]. MINERVA UROL NEFROL 1999; 51:137-41. [PMID: 10638176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
|
42
|
Casetta G, De Zan A, Moiso A, Zitella A, Viberti L, Tizzani A. [Rare renal tumors (neoplasms other than conventional renal cell carcinoma). Clinico-pathologic aspects and review of the literature]. MINERVA UROL NEFROL 1999; 51:149-56. [PMID: 10638178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
The clinical and pathological findings in 94 patients with surgically confirmed renal neoplasm from 1990 to 1998 have been retrospectively reviewed and a literature review is made. The heterogeneous group of rare renal tumours has been particularly considered: renal oncocytoma and oncocytomatosis, renal angiomyolipoma and renal medullary fibroma; chromophobe renal cell carcinoma (RCC), papillary RCC, multiple primary malignant RCC, hereditary RCC, renal sarcoma and sarcomatoid RCC, renal malignant fibrous histiocytoma, renal hemangiopericytoma and renal lymphoma.
Collapse
Affiliation(s)
- G Casetta
- Dipartimento di Discipline Medico-Chirurgiche, Università degli Studi, Torino
| | | | | | | | | | | |
Collapse
|
43
|
Zitella A, Moiso A, De Zan A, Casetta G, Piana P, Tizzani A. Recurrent calcium oxalate urolithiasis in a man with familial periodic paralysis and hypokalemia. J Urol 1999; 161:1899. [PMID: 10332462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/13/2023]
Affiliation(s)
- A Zitella
- Department of Urological Pathology, University of Torino, Italy
| | | | | | | | | | | |
Collapse
|
44
|
Greco A, Giammò A, Tizzani A. [Nephrogenic adenoma arising from an urethral diverticulum in a female. Report of a case and review of the literature]. MINERVA UROL NEFROL 1999; 51:39-43. [PMID: 10222760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
Abstract
Nephrogenic adenoma is a benign epithelial tumour localised at the level of the urothelium and caused by metaplasia of the urothelium following prolonged aggressive stimulation over time, for example trauma or chronic urinary infection. Even a diverticulum, in whatever site it is localised, is subject to an increased risk of neoplastic transformation of the urothelium. It above all affects male subjects, with a male/female ratio of 3:1 over the age of 20, which is inverted in younger subjects. The most frequently affected site is the vescical trigonum in 72% of cases, followed by the pelvic tract of the ureter (19%) and urethra. The majority of patients is asymptomatic or reports aspecific symptoms: the most frequent picture is macroscopic hematuria, owing to the rich vascularisation of the tumour. This is followed by irritative type signs such as pollakiuria, strangury, posturination dripping and sometimes painful tenesmus. Differential diagnosis is necessary for pale cell adenocarcinoma, parauretral cysts and Gartner duct's cysts which may be associated with urethral diverticulum, localised on the bottom, and rarely symptomatic. Diagnosis is based on retrograde urethrography, cystography and endoscopic tests, with biopsy if necessary. NMR provides further details regarding the site, localisation and benign or malignant nature of the lesion. Treatment is surgical: endoscopic (transurethral) if the dimension are limited, or traditional using a suprapubic or transvaginal route if it is associated with diverticulum. Prognosis is discrete and depends on the timeliness with which the factors predisposing metaplasia are eliminated.
Collapse
Affiliation(s)
- A Greco
- Dipartimento di Discipline Medico-Chirurgiche, Università degli Studi, Torino
| | | | | |
Collapse
|
45
|
Tizzani A, Gontero P, Casetta G, Piana P, Baima C, De Zan A, Bodo G, Pacchioni D. Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results. Prostate Cancer Prostatic Dis 1999; 2:16-20. [PMID: 12496861 DOI: 10.1038/sj.pcan.4500268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/1998] [Revised: 08/27/1998] [Accepted: 09/23/1998] [Indexed: 11/09/2022]
Abstract
Short term follow up studies on transurethral electrovaporization (TUEVP) have shown a relative low morbidity over TURP. The use of high power current has been claimed as a source of possible damage on the neuronal structures surrounding the prostate. The aims of our study were to assess longer follow up results as well as the safety of this technique. Over an 18 month mean follow up period symptom relief remained relatively stable. Postoperative dysuria was detected in a higher percentage of patients and was seen for a longer period in comparison with previous reports. Immunohistochemical staining performed using S-100 and NF monoclonal antibodies showed anatomical integrity of the prostatic neuronal fibres surrounding the vaporization edge. In conclusion, although the effectiveness and safety of TUEVP are confirmed by the present study, the occurrence of a significant rate of long-lasting postoperative irritative symptoms must be taken into account.
Collapse
|
46
|
Bodo G, Gontero P, Casetta G, Alpa M, Brossa G, Russo R, Tizzani A. Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal. Scand J Urol Nephrol 1998; 32:320-4. [PMID: 9825393 DOI: 10.1080/003655998750015269] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Persistence of nocturia after prostatic resection in healthy patients without symptoms referred to residual bladder instability and to pathological polyuria seems to be caused by an increased urine production at night. The more accreditate mechanism involved is the relevant decreased ADH secretion pattern which occurs at night. In our study, patients with nocturnal poliuria showed significantly low plasmatic vasopressin levels compared with a control group. The aim of this study was to evaluate whether the persistence of nocturia after prostatic resection in healthy patients, without symptoms referred due to residual bladder instability and important polyuria, could be due to a decrease or a lack of increase in antidiuretic hormone (ADH) nocturnal levels following increased urine production at night. Serum ADH, atrial natriuretic peptide (ANP) and osmolality were assessed at 4-h intervals in 12 patients complaining of residual nocturia (group A) and in a control group of 13 patients who had undergone a complete resolution of nocturia after prostate ablation (group B). In the 25 patients involved in the study (mean age 65.8 years), no significant differences were observed in the two groups concerning mean age (67.5 years for group A, 64 years for group B). Mean nocturnal urine volume (1080 +/- 490 ml) in group A patients was significantly higher than in group B (500 +/- 100 ml) (p < 0.001), while no significant differences were found in diurnal diuresis. Mean plasma vasopressin levels of the 12 patients showing an increased nocturnal micturition were found to be significantly lower at all 4-h intervals when compared with the control group (p < 0.05). Individual fluctuations in serum osmolality were slight and insignificant within the normal range in all patients. The diurnal variation of plasma atrial natriuretic peptide was within the reference limits for all subjects during the 24-h period. Our results lead us to believe that residual nocturia after prostatic resection seems to be caused by an increased urine production at night due to a decreased ADH secretion pattern.
Collapse
Affiliation(s)
- G Bodo
- University of Torino, Italy
| | | | | | | | | | | | | |
Collapse
|
47
|
Casetta G, De Zan A, Vella R, Moiso A, Tizzani A. [Renal multifocal carcinoma with adrenal gland metastasis in a patient previously treated with radical nephrectomy: what kind of therapy. Review of the literature]. MINERVA UROL NEFROL 1997; 49:215-7. [PMID: 9557505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
A case of multiple adrenal metastases due to renal cells carcinoma, associated with a multifocal simultaneous renal cells carcinoma has been observed in a female patient previously submitted to radical contralateral nephrectomy for the same disease. In particular, stress is laid on computerized tomography scan diagnosis and surgical procedure.
Collapse
Affiliation(s)
- G Casetta
- Divisione Universitaria di Patologia Urologica, Azienda Ospedaliera Molinette, Università degli Studi, Torino
| | | | | | | | | |
Collapse
|
48
|
Tizzani A, Casetta G, Gontero P, Giammò A, Ghabin H, Demurtas S, Pacchioni D. DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder. MINERVA UROL NEFROL 1997; 49:141-3. [PMID: 9396221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Using flow cytometry, gross genomic alterations, defined as DNA ploidy, and the fraction of S-phase cells, can be calculated in bladder cancer cells. In aneuploid superficial bladder cancer the recurrence rate has been reported to be three times higher than in diploid forms. A correlation between the S-phase fraction and progression has been reported for G1-G2/Ta-T1 tumours, but not for G3/Ta-T1. The aim of our study is to evaluate whether the traditional cytometric parameters can be used as valid predictors of early recurrences and progression in G1-G2/Ta-T1 and G3/Ta-T1 bladder cancer patients and to compare the proliferation indexes as defined by S-phase fraction and 67Ki monoclonal antibody in the two groups of patients.
Collapse
|
49
|
Piana P, De Zan A, Giammò A, Tizzani A. [Biophysical principles of tissue electrovaporization]. MINERVA UROL NEFROL 1997; 49:151-6. [PMID: 9432737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The principles of electrosurgery are based upon well defined physical grounds, explaining the type and extent of the lesions induced by the electric current. Technological evolution has led to the creation of dedicated equipment, allowing efficient use of electrosurgical cutting and coagulation of tissues, both in open and endoscopic surgery. Electrovaporization is the thermal effect obtained when an alternating high power-high frequency current (300 W, 400-500 kHz) is applied to the tissue using an electrode with particular geometric aspects. The main feature is the presence of higher and lower current density zones. The first induce electrovaporization, whilst the second produce simultaneous hemostatic coagulation of the rims. New effective vaporizing electrodes have been recently introduced into clinical practice. Their use in the endoscopical treatment of bladder outlet obstructions, a stimulating alternative to standard resection or laser applications, is currently under evaluation.
Collapse
Affiliation(s)
- P Piana
- Divisione Universitaria di Patologia Urologica, Università degli Studi, Torino
| | | | | | | |
Collapse
|
50
|
Montrucchio G, Lupia E, de Martino A, Battaglia E, Arese M, Tizzani A, Bussolino F, Camussi G. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Am J Pathol 1997; 151:557-63. [PMID: 9250168 PMCID: PMC1858000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
We evaluated the role of an endogenous production of nitric oxide (NO) in the in vitro migration of endothelial cells and in the in vivo angiogenic response elicited by platelet-activating factor (PAF), tumor necrosis factor-alpha (TNF), and basic fibroblast growth factor (bFGF). The NO synthase inhibitor, N omega-nitro-L-arginine-methyl ester (L-NAME), but not its enantiomer D-NAME, prevented chemotaxis of endothelial cells induced in vitro by PAF and by TNF. The motogenic activity of TNF was also inhibited by WEB 2170, a specific PAF-receptor antagonist. In contrast, chemotaxis induced by bFGF was not prevented by L-NAME or by WEB 2170. Angiogenesis was studied in vivo in a murine model in which Matrigel was used as a vehicle for the delivery of mediators. In this model, the angiogenesis induced by PAF and TNF was inhibited by WEB 2170 and L-NAME but not by D-NAME. In contrast, angiogenesis induced by bFGF was not affected by L-NAME or by WEB 2170. TNF, but not bFGF, induced PAF synthesis within Matrigel. These results suggest that NO mediates the angiogenesis induced by PAF as well as that induced by TNF, which is dependent on the production of PAF. In contrast, the angiogenic effect of bFGF appears to be both PAF and NO independent.
Collapse
Affiliation(s)
- G Montrucchio
- Dipartimento di Fisiopatologia Clinica, Università di Torino, Italy
| | | | | | | | | | | | | | | |
Collapse
|